Filter by
 

Origin

Publication date

Category

Main subject

Main subject

Keywords

Keywords

Geographical scope

Document language

EMCDDA Document Library

Displaying 51 - 60 of 85

Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme

September 2015

In Athens, Greece, the ARISTOTLE intervention for identifying HIV-positive people among people who inject drugs (PWID) facilitated rapid identification of a hidden population experiencing an outbreak and provided HIV testing, counselling and linkage to care.

Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction

July 2015

Supervised injectable heroin (SIH) is found to be an effective way of treating heroin dependence in a patient population previously considered unresponsive to treatment. It can improve the impact of comprehensive healthcare provision but requires more attention to safety issues.

Fentanyls: are we missing the signs? Highly potent and on the rise in Europe

July 2015

Fentanyl is a synthetic opioid analgesic historically used as a pain reliever and an anaesthetic. In the European context, fentanyls are ‘low use but high risk/harm’ substances. Developments in illicit supply of fentanyls reflect the complexity of Europe's contemporary drug market; effective and...

Evaluation of drug consumption rooms (Denmark)

May 2015

In 2015, the Ministry of Health carried out an evaluation based on the 2014 annual reports provided by the municipal authorities of the three cities with permission to establish and operate drug consumption rooms.

HCV promotional material example: Hepatitis? HIV? Ein Test schafft Klarheit! - Kurzinfos für Drogengebraucher

April 2015

The leaflet covers information about hepatitis and HIV testing. It explains the interpretation of the results and provides information on the benefits of testing. It is a brief information for drug users.

Annual expert meeting on Drug-related deaths (DRD) and Drug-related infectious diseases (DRID) – Preliminary summary and highlights of the meeting

November 2014

Two EMCDDA expert meetings, dedicated to the agency’s drug-related deaths and mortality among drug users indicator (DRD) and the drug-related infectious diseases indicator (DRID), were held in Lisbon from 15–17 October. This three-day event gathering the DRD and DRID key indicator networks offered...

Meeting minutes: Take home naloxone to reduce fatalities: scaling up a participatory intervention across Europe, October 2014

November 2014

These are the minutes from a meeting organised by the EMCDDA on 14 October 2014 in Lisbon, entitled 'Take home naloxone to reduce fatalities: scaling up a participatory intervention across Europe'. The minutes include the original agenda and a summary of proceedings from the sessions. 

Trajectories of injecting behavior in the Amsterdam Cohort Study among drug users

November 2014

Longitudinal injecting patterns were similar in the cohort to earlier US reports. Duration of injecting/year of cohort entry were associated with these patterns. Changes in injecting of drugs over time were mirrored in the incidence of HIV.

Take home naloxone to reduce fatalities: scaling up a participatory intervention across Europe (meeting report)

October 2014

Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis

September 2014

Identifies key actions suggested by lessons learned from the three-plus decades of the HIV epidemic which can be applied to the prevention of hepatitis among drug users.

Loading